how long have glp-1 drugs been on the market Agonists Report 2025-2033, By Product, Molecule, and Geo How Supply and Demand for
Description
J.et al (2021)
Over time, GeneDx plans to expand into newborn screening, a potentially $10 billion marketthen eventually into adult screening to replace multi-gene panel and individual gene tests, a future market pegged at $16 billion, Katherine Stueland, GeneDxs president and CEO, told GEN Edge last month With tougher comps in 25 and a potential headwind to revenues emerging in HCT, it is harder to argue for multiple expansion from here, Peterson said
vomiting 2%6% vs
Lancet Diabetes Endocrinol 2024;12:51-60.PubMed 54
It's important in a number of different ways
doi: 10.1111/dom.12432 64 GeS.GohE
